Skip to main content
. 2022 Oct 7;8:104. doi: 10.1038/s41421-022-00463-6

Fig. 1. Isolation of three non-Omicron NAbs from COVID-19 convalescent individuals.

Fig. 1

a Binding of GW01, 16L9, and 4L12 to the SARS-CoV-2 RBD, Omicron RBD and trimer in an ELISA. REGN10987 was used as a control. b Neutralizing activities of GW01, 16L9, and 4L12 and their combinations against pseudotyped SARS-CoV-2 and its variants Alpha, Beta, Gamma, Delta, and Omicron, as well as sarbecoviruses. S309 was used as a positive control. c Binding of 4L12, 16L9, and RGN10987 to the SARS-CoV-2 RBD in competition with GW01, as measured by BLI.